Shukra Pharmaceuticals Ltd vs Torrent Pharmaceuticals Limited

A side-by-side comparison of Shukra Pharmaceuticals Ltd (SHUKRAPHARMACEUTICALSLTD) and Torrent Pharmaceuticals Limited (TORNTPHARM) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.

The verdict

Shukra Pharmaceuticals Ltd vs Torrent Pharmaceuticals Limited are evenly matched on the numbers (7–7). The breakdown below shows where each one wins.

  • Valuation13
  • Profitability40
  • Growth11
  • Size & financial health13
ValueReturnsMarginGrowthScaleLow debt

Each axis shows this group's split of that metric, scaled so the leader sits at the edge. Relative to each other, not an absolute score.

Valuation

TORNTPHARM takes 3/4

How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.

72.80
P/E ratio
71.32
16.66
P/B ratio
22.29
0.03%
Dividend yield
0.77%
₹0.22
EPS
₹63.92

Profitability

SHUKRAPHARMACEUTICALSLTD takes 4/4

How efficiently each company turns capital and sales into profit. Higher is better.

28.90%
Return on equity
25.78%
22.00%
Return on capital
13.91%
39.00%
EBITDA margin
32.61%
30.30%
Net margin
15.29%

Growth

Even

Three-year compounded growth. Faster-growing businesses can justify a higher valuation.

-1.31%
Revenue CAGR (3Y)
13.27%
70.51%
Profit CAGR (3Y)
19.75%

Size & financial health

TORNTPHARM takes 3/4

Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.

₹1,706 Cr
Market cap
₹1.73L Cr
₹33 Cr
Revenue
₹13,980 Cr
₹10 Cr
Net profit
₹2,138 Cr
0.06
Debt / equity
1.79
Shukra Pharmaceuticals Ltd
  • + ["Company is almost debt free.", "Company is expected to give good quarter", "Company has delivered good profit growth of 175% CAGR over last 5 years", "Company has a good return on equity (ROE) track record: 3 Years ROE 28.2%"]
  • − ["Stock is trading at 19.0 times its book value", "Debtor days have increased from 122 to 148 days."]
Torrent Pharmaceuticals Limited
  • + ["Company has a good return on equity (ROE) track record: 3 Years ROE 26.2%", "Company has been maintaining a healthy dividend payout of 67.6%"]
  • − ["Stock is trading at 20.67 times its book value", "Company has a high debt to equity ratio of 1.79."]
Shukra Pharmaceuticals Ltd full analysis Torrent Pharmaceuticals Limited full analysis

This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.

SHUKRAPHARMACEUTICALSLTD vs TORNTPHARM: Share Price, Valuation & Which to Buy | DocStoX